DexCom, Inc. (DXCM) Stock Price

DXCMStock
$89.16+10.70%52W
Market Cap$33.65B
P/E41.28x
PEG Ratio1.74
Div yield
Beta1.47

DXCM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)13.84%
Price vs S&P 500 (4W)18.60%
PEG Ratio1.74
VGM Score61.75
P/E Ratio (Annual)41.28x

DXCM Earnings Surprise History

Q2 250.48est. 0.44
Q3 250.61est. 0.57
Q4 250.68est. 0.65
Q1 260.56est. 0.47
Q2 260.70est. 0.61

DXCM Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.24
4.27
4.26
4.28

Industry Peers — Surgical & Medical Instruments(140)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
DXCMDexCom, Inc.
DBB$89.16
SYKStryker CorporationCBC$330.59
MMM3M CompanyCDB$179.37
BSXBoston Scientific Corp.CBD$49.86
BDXBecton, Dickinson and Co.BDB$189.78
MDLNMedline Inc. Class A common stockCDC$35.64
RMDResMed Inc.CBC$236.59
WSTWest Pharmaceutical Services, Inc.DCB$348.48
SOLVSolventum CorporationCCB$91.61
BAXBaxter International Inc.BDB$26.29
PENPenumbra, Inc.DCC$324.37

About DexCom, Inc.

DexCom manufactures continuous glucose monitoring systems that provide an alternative to traditional blood glucose testing for diabetes management. The company's CGM technology integrates with insulin pumps from Insulet and Tandem to enable automated insulin delivery. Products are distributed through medical equipment distributors and retail pharmacies.